BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
This Quarter Return
+41.34%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.59B
AUM Growth
+$1.59B
Cap. Flow
+$280M
Cap. Flow %
17.58%
Top 10 Hldgs %
83.78%
Holding
29
New
7
Increased
2
Reduced
3
Closed
3

Top Buys

1
AVIR icon
Atea Pharmaceuticals
AVIR
$235M
2
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$62.8M
3
CCCC icon
C4 Therapeutics
CCCC
$54.4M
4
SLDB icon
Solid Biosciences
SLDB
$24.2M
5
APTX
Aptinyx Inc. Common Stock
APTX
$11.5M

Top Sells

1
REPL icon
Replimune Group
REPL
$48.9M
2
SAGE
Sage Therapeutics
SAGE
$30.5M
3
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$22M
4
KYMR icon
Kymera Therapeutics
KYMR
$15.5M
5
PANA.U
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
$5M

Sector Composition

1 Healthcare 93.91%
2 Financials 0.53%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
$528M 33.15% 7,281,307 – –
AVIR icon
2
Atea Pharmaceuticals
AVIR
$267M
$235M 14.73% +5,615,659 New +$235M
ARQT icon
3
Arcutis Biotherapeutics
ARQT
$1.86B
$112M 7.03% 3,979,292 – –
MRSN icon
4
Mersana Therapeutics
MRSN
$36.5M
$91.7M 5.76% 3,445,667 – –
ANNX icon
5
Annexon
ANNX
$226M
$81.1M 5.09% 3,241,628 – –
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$67.9M 4.26% 3,080,237 -1,000,000 -25% -$22M
SYRS
7
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$62.8M 3.94% +5,785,036 New +$62.8M
CCCC icon
8
C4 Therapeutics
CCCC
$185M
$54.4M 3.42% +1,642,209 New +$54.4M
SLDB icon
9
Solid Biosciences
SLDB
$427M
$53.5M 3.36% 7,060,353 +3,189,189 +82% +$24.2M
DVAX icon
10
Dynavax Technologies
DVAX
$1.19B
$48.5M 3.04% 10,895,773 – –
NRIX icon
11
Nurix Therapeutics
NRIX
$714M
$42.2M 2.65% 1,284,314 – –
CNST
12
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$40.3M 2.53% 1,400,000 – –
APTX
13
DELISTED
Aptinyx Inc. Common Stock
APTX
$30.8M 1.93% 8,891,758 +3,333,333 +60% +$11.5M
KYMR icon
14
Kymera Therapeutics
KYMR
$2.95B
$29.7M 1.87% 479,605 -250,001 -34% -$15.5M
SYRE icon
15
Spyre Therapeutics
SYRE
$996M
$21.2M 1.33% 2,700,000 – –
MRNS
16
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$17.5M 1.1% 1,431,058 -1 -0% -$12
CRNX icon
17
Crinetics Pharmaceuticals
CRNX
$2.92B
$15.1M 0.95% 1,071,428 – –
PNT
18
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$13.9M 0.87% 1,000,000 – –
NAUT icon
19
Nautilus Biotechnolgy
NAUT
$85.9M
$10.9M 0.68% 1,000,000 – –
XFOR icon
20
X4 Pharmaceuticals
XFOR
$84.2M
$10.6M 0.67% 1,648,485 – –
SVRA icon
21
Savara
SVRA
$567M
$5.9M 0.37% 5,128,593 – –
TNGX icon
22
Tango Therapeutics
TNGX
$747M
$5.72M 0.36% 500,000 – –
BLSA
23
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.43M 0.34% +487,500 New +$5.43M
FLACU
24
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$3.11M 0.2% +300,000 New +$3.11M
JYAC
25
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$3.09M 0.19% +300,000 New +$3.09M
1
2